netFormulary Oxfordshire Clinical Commissioning Group NHS
Formulary  
 Search
 Formulary Chapter 10: Musculoskeletal and joint diseases - Full Chapter
10.01.04  Expand sub section  Gout and cytotoxic-induced hyperuricaemia
10.01.04  Expand sub section  Acute attacks of gout
10.01.04  Expand sub section  Long-term control of gout
Allopurinol
View adult BNF View SPC online View childrens BNF
Formulary
Green
 
   
Febuxostat (Adenuric® )
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Brown

For the management of hyperuricaemia in people with gout who are unable to take or intolerant to allopurinol as per NICE TA164.

APCO March 2010.

 
Link  NICE TA164: Hyperuricaemia - febuxostat
Link  MHRA: Advice regarding risk of serious hypersensitivity reactions
   
Sulfinpyrazone
View adult BNF View SPC online View childrens BNF
Formulary
Amber Continuation

Suitable for continuation in primary care following specialist initiation.

 
   
Probenecid
View adult BNF View SPC online View childrens BNF
Unlicensed Drug Unlicensed
Red

For severe gout or hyperuricaemia (unlicensed).

 
Link  BASHH - UK national guidelines on the management of syphilis 2015. For reference only, refer all patients to GUM
   
10.01.04  Expand sub section  Hyperuricaemia associated with cytotoxic drugs
 ....
 Non Formulary Items
Pegloticase  (Krystexxa®)

View adult BNF View SPC online View childrens BNF
Non Formulary
Black

Not recommended for treating severe debilitating chronic tophaceous gout as per NICE TA291.

APCO July 2013.

Link  NICE TA291: Pegloticase for treating severe debilitating chronic tophaceous gout
 
  
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Red

Red: Medicines which should only be prescribed in secondary care by a specialist.  

Amber Continuation

Amber Continuation: Medicines which should be initiated or recommended by a specialist for continuation in primary care. The specialist must notify the GP that the prescribing responsibility has been transferred.   

Amber Shared Care Protocol

Amber Shared Care Protocol: Medicines which are appropriate to be initiated and stabilised by a specialist, once stabilised the medicine may be appropriate for responsibility to be transferred from secondary to primary care with the agreement of a GP and a formal ‘shared care’ agreement. The shared care protocol must be approved by the Area Prescribing Committee Oxfordshire (APCO).   

Green

Green: Medicines which are suitable for initiation and ongoing prescribing within primary care.   

Brown

Brown: Medicines which should only be prescribed in restricted circumstances.  

Black

Black: Medicines which are not recommended for use because of lack of evidence of clinical effectiveness, cost effectiveness or safety.  

OCCG Green

not used  

netFormulary